Accuray Incorporated
BrainLab
Elekta AB
GE Healthcare
Hitachi America
Download the full report: https://www.reportbuyer.com/product/98399/
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
Linear Accelerator I-3
Treatment Planning System I-4
Radiation Therapy Simulator I-4
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW II-1
Global Market for Radiotherapy - A Synopsis II-1
Radiation Therapy Equipment and Software Market Bounces Back
from Recession II-2
Table 1: Healthcare Spending as a Percentage of GDP in Select
Countries (includes corresponding Graph/Chart) II-3
Table 2: Per-Capita Healthcare Expenditure in Select Regions
(2013) (includes corresponding Graph/Chart) II-4
Current and Future Analysis II-5
North America - The Most Advanced and Dominant Global Market
for Radiotherapy II-6
US Leads in Penetration of LINACs II-6
Table 3: Installed Base of Linacs Per Million Inhabitants
for Select Geographic Regions/ Countries (2013) (includes
corresponding Graph/Chart) II-7
Developing Nations Offer Lucrative Opportunities II-8
Table 4: Top 20 Countries with the Highest Healthcare
Spending as a Percentage of GDP (2012) (includes
corresponding Graph/Chart) II-9
Asia-Pacific - A Highly Promising Market II-9
2. MARKET DYNAMICS II-11
Expanding Aging Population Raises Risk of Cancer, Drives
Demand for Radiation Therapy Solutions II-11
Table 5: Global Population Statistics for the 65+ Age Group
(2013) (includes corresponding Graph/Chart) II-12
Table 6: Elderly Population (60+ Years) as a Percentage of
the Total Population (2012 & 2050) (includes corresponding
Graph/Chart) II-13
Table 7: Life Expectancy at Age 60 and 80 Years -
(2010-2015), (2020-2025) & (2045-2050) (includes
corresponding Graph/Chart) II-13
Replacement Sales Drive Radiotherapy Market in Developed Markets II-14
Table 8: Percentage of Patients Provided Radiation Therapy in
Developed Markets (2013) (includes corresponding Graph/Chart) II-15
Table 9: Global Installed Base of LINACs (2013): Percentage
Share Breakdown by Volume of Units Installed for North
America, Europe, Asia Pacific (Including Japan) & Middle
East, South America, and Africa (includes corresponding
Graph/Chart) II-15
Improving Healthcare Expenditure Turbo Charges Demand II-16
Table 10: Per-Capita Healthcare Expenditure in Select Regions
(2013) (includes corresponding Graph/Chart) II-16
External Beam Radiation Therapy Equipment Corners Lion's Share
of Market II-17
Table 11: Global Radiation Therapy Equipment Market by Type
(2014): Market Share Breakdown of Sales Revenues for External
Beam Radiation Therapy (EBRT), Brachytherapy, and Others
(includes corresponding Graph/Chart) II-17
LINACS Increasingly Replace Conventional Equipment II-17
Demand for Oncology Information Systems (OIS) on Rise II-18
Data-Intensive Radiation Oncology Promotes OIS Connection to
EHRs II-18
Treatment Planning - Grows in Significance II-19
Need for Boosting Productivity of Existing Cancer Care Centers
Drives Demand for New Technologies II-19
Technological Innovations Improve Treatment Accuracy II-20
Personalized Radiation Therapy - The Way Forward II-20
Hospitals Focus on Buying IMRT-Capable LINACs II-21
Types of IMRT II-22
Rotational IMRT Gains Popularity II-22
Stereotactic Radio Surgery - A Treatment with Rising Preference II-22
Adaptive Radiation Therapy (ART) Gains Significance II-23
IGRT Gaining Ground II-23
Shortage of Medical Professionals & Systems - A Major Obstacle II-24
Patient Comfort - A Significant Concern Affecting Treatment
Accuracy II-24
3. PROTON THERAPY - AN INSIGHT II-25
Proton Therapy - Revolutionizing the Industry II-25
Table 12: World Recent Past, Current & Future Analysis for
Proton Therapy by Geographic Region - US, Japan, Europe,
Asia-Pacific (excluding Japan), and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) II-26
Table 13: World 7-Year Perspective for Proton Therapy by
Geographic Region - Percentage Breakdown of Value Sales for
US, Japan, Europe, Asia-Pacific (excluding Japan), and Rest
of World Markets for Years 2014 & 2020 (includes
corresponding Graph/Chart) II-27
IMPT - The Future of Proton Therapy II-27
High Cost - A Barrier to Adoption II-28
Technological Advancement to Lower Cost of Therapy II-28
4. COMPETITION II-29
Competitive Landscape II-29
Table 14: Leading Global Players in Radiation Therapy
Equipment Market (2013): Percentage Share Breakdown by Sales
for Varian, Elekta, Accuray, Siemens, and Others (includes
corresponding Graph/Chart) II-30
Exit of Siemens Healthcare Opens Doors for Windfall Gains II-30
Table 15: Siemens Healthcare Worldwide Installed Base of
Linear Accelerators (2013) (includes corresponding
Graph/Chart) II-31
Competition in the LINAC Segment II-31
Table 16: Leading Players in Global LINAC Market (2012):
Percentage Share Breakdown by Volume of Units Installed for
Varian, Elekta, Siemens and Others (includes corresponding
Graph/Chart) II-32
Stereotactic Radiosurgery Systems (SRS) - Market Scenario II-32
Table 17: Leading Players in SRS/SBRT Market (2013):
Percentage Share Breakdown by Volume Sales for Elekta,
BrainLab, Accuray and Others (includes corresponding
Graph/Chart) II-32
Proton Therapy Equipment Market Marked by Intense Competition II-32
Table 18: Leading Global Players in Proton Therapy Market
(2013): Percentage Share Breakdown by Operational Installed
Base for IBA, Hitachi, Mitsubishi, Varian and Sumitomo
(includes corresponding Graph/Chart) II-33
Competitive Landscape in Treatment Planning Systems Market II-33
Table 19: Global Treatment Planning Systems Market by
Leading Players (2013): Market Share Breakdown for Installed
Base for Elekta/Nucletron, Philips, Varian and Others
(includes corresponding Graph/Chart) II-34
5. CANCER - A GLOBAL CONCERN II-35
Cancer Incidence - Statistics on New Cases II-35
Table 20: Worldwide Incidence of Cancer (2013, 2020 & 2030):
Number of New Cases Diagnosed (includes corresponding
Graph/Chart) II-35
Table 21: New Cancer Cases in the World by Affected Site:
2012 (in Thousands) (includes corresponding Graph/Chart) II-36
Table 22: Global Cancer Incidence by Income Group: 2012 (in
Thousands) (includes corresponding Graph/Chart) II-37
Table 23: Cancer Incidence in High Income Countries by Site:
2012 (in Thousands) (includes corresponding Graph/Chart) II-37
Table 24: Cancer Incidence in Upper Middle Income Countries
by Site: 2012 (in Thousands) (includes corresponding
Graph/Chart) II-38
Table 25: Cancer Incidence in Lower Middle Income Countries
by Site: 2012 (in Thousands) (includes corresponding
Graph/Chart) II-39
Table 26: Cancer Incidence in Low Income Countries by Site:
2012 (in Thousands) (includes corresponding Graph/Chart) II-40
Cancer Incidence in Developing Countries II-40
Cancer in Asia II-41
Cancer Cases - Mortality Rates II-41
6. RADIATION THERAPY: AN OVERVIEW II-42
Radiation Therapy - A Panacea for all Cancer Diseases II-42
Milestones in Evolution of Cancer Care Technologies II-43
Treatment Scenario II-43
Table 27: Major Body Sites for Administration of
Radiotherapy: Percentage Breakdown of Frequency of
Application of Radiation Treatment for Breast, Prostate,
Lung, Head & Neck, and Other Body Sites (includes
corresponding Graph/Chart) II-44
Radiation Therapy Treatment Team II-44
Types of Radiation Therapy II-44
External Beam Radiation Therapy (EBRT/XRT) or Teletherapy II-45
Conventional External Beam Radiotherapy II-45
Stereotactic Radiation II-45
Particle Therapy or Proton Therapy II-45
Auger Therapy II-46
Internal Beam Radio Therapy/Brachytherapy II-46
More About Brachytherapy II-46
Technical Scope of Brachytherapy II-47
Systemic Radioisotope Therapy (RIT) II-47
Radiation Therapy for Treating Oral Cancer II-47
Other Forms of Radiation Therapy II-48
Photoradiation Therapy (PRT) II-48
Photodynamic Therapy (PDT) II-48
Cost of Radiation Therapy II-48
Limitations of Conventional Radiation Therapy Techniques II-48
Overview of Radiotherapy Equipment II-49
External Beam Therapy Devices II-49
CyberKnife II-49
Gamma Knife II-49
TomoTherapy II-50
LINACs II-50
Comparison of Select Radiotherapy Systems II-50
Proton Therapy Devices II-51
7. PRODUCT OVERVIEW II-52
Introduction II-52
Landmarks in Evolution of Cancer Care II-52
Linear Accelerator II-52
Accelerator - Down to Nuts & Bolts II-52
Clinical Demands and Device Characteristics II-53
Dual X-ray Energy Linear Accelerator - Numerous Energy
Offerings II-54
Price - A Direct Functionality of Features II-54
Beam Energy and Dose Rates - Deciding Factors II-54
Isocentric Units - The Prevalent Form in Accelerators II-54
Subsystem Design Factors II-55
Bending Magnet Systems - For Smooth Functioning II-55
Dosimetry System - Regulating the Radiation Dosage II-55
Beam Steering Systems - Directing the Flow II-56
Cobalt-60 II-56
Characteristics of Cobalt-60 Machines II-56
Major features of Cobalt-60 Radioisotope II-56
Competitive Edge: Cobalt 60 Units vs. Linear Accelerators II-57
Comparative Assessment of Cobalt-60 Teletherapy Units and
Linear Accelerators II-57
Benefits of LINACs over Cobalt 60 Units II-58
Treatment Planning System: An Innovative Technique in
Radiation Therapy II-58
Radiation Therapy Simulator II-59
CT Simulation Systems II-59
Major Systems of Radiation Therapy Simulator II-60
Mechanical Systems II-60
Principles of Operations II-61
8. RADIOTHERAPY ACCESSORIES II-62
Introduction II-62
Tumor Localization and Treatment Simulation Devices II-62
Patient Restraint and Repositioning Devices II-62
Different Types of Patient Restraint and Repositioning Devices II-63
Patient Targeting System II-63
Field-Shaping Devices II-63
Dose-Modifying Devices II-64
Treatment Setup and Delivery Devices II-65
Breast Bridge with a Rolling-Ball Angle Inclinometer II-65
Squeeze Bridge Device II-65
Beam Alignment Device II-66
Arm Board II-66
Tilt Board II-66
Shoulder Reactor II-66
Mylar Window Table Insert II-66
Clamps II-66
Treatment Verification and Quality Assurance Devices II-66
Need for Surgery and Radiotherapy Likely to Diminish II-67
9. CANCER THERAPY - EPIDEMIOLOGY II-68
Four Progressive Stages of Cancer II-68
Types of Cancer II-68
Breast Cancer II-69
Treatment Options II-69
Major Developments in the Treatment Area of Breast Cancer II-69
Colorectal Cancer II-70
Prostate Cancer II-70
Pancreatic Cancer II-71
Cervical Cancer II-71
Esophageal Cancer II-71
Lung Cancer II-71
Treatment Options Available II-72
Technological Developments II-72
Cures II-72
Enhanced Therapies II-72
Prevention and Public Awareness II-72
Better Screening and Earlier Detection II-72
Other Emerging Therapies II-73
10. CANCER TREATMENT - A COST ANALYSIS II-74
Table 28: Cancer Treatment Costs by Modality II-74
Medicare and Medicaid Reimbursement II-74
Coverage II-75
Coding II-75
Payment II-75
11. NEW FRONTIERS IN RADIATION THERAPY II-76
Increasing Role of Imaging in Treatment Planning II-76
MRI to Attain Optimum Outcomes II-76
Positron Emission Tomography II-76
Convergence of PET and CT Images for Treatment Planning II-76
Dynamic contrast-enhanced CT/MRI II-77
Copper(II)-diacetyl-bis(N4-methylthiosemicarbazone) PET (Cu-
ATSM PET) II-77
Four-Dimensional CT Scanning II-77
4D Adaptive Radiation Therapy - Adds a New Dimension II-77
MRI-Linacs - To Revolutionize Cancer Care II-78
Nano Particles in Cancer Treatment II-78
Microbeam Radiation Therapy Revisited II-79
Unleashing the Power of Plasma II-79
ION Beam Therapy Gains Attention II-80
Volumetric Modulated Arc Therapy (VMAT) II-80
Mobetron™ - Radiation Therapy on the Wheels II-80
3-D Conformal Radiation Therapy: A New Technology II-81
World's First 3-D Image-Guided Radiation Therapy System from
Elekta II-81
Evolving Technology Arms TomoTherapy with an Edge over
Competition II-81
High Dose Radiation Treatment Found to Reduce Side Effects in
Prostate Cancer Treatment II-82
12. PRODUCT INNOVATIONS/INTRODUCTIONS II-83
National Institute for Health and Care Excellence Introduces
INTRABEAM radiotherapy II-83
IBA Inks Collaboration Agreement with Mobius Medical Systems II-83
Mirada Medical Enters into Agreement with RefleXion Medical
for Research Collaboration II-83
Radyalis and NVIDIA Announce Research Collaboration II-83
IBA Releases OmniPro I'mRT + Software II-83
Elekta Launches Advanced Versa HD Linear Accelerator System II-83
Ion Beam Applications (IBA) Unveils COMPASS 3.0 Plan
Verification System II-84
Alfred Health's WBRC Introduces Brainlab ExacTrac Adaptive
Gating System for Cancer Therapy II-84
Elekta Unveils New Monaco 5.0 Fully Integrated Radiation
Treatment Planning System II-84
Accuray Launches New TomoTherapy® H™ Series Technology II-84
Accuray and MIM Software to Launch Co-branded Version of
Mobile MIM 3.0 II-84
MIM Launches Upgraded Mobile MIM 3.0 II-84
Elekta Launches New Monaco® 3.0 DCA Treatment Planning System II-84
13. RECENT INDUSTRY ACTIVITY II-85
iCAD Takes Over Radion and DermEbx II-85
Elekta Gains Approval from Japanese Ministry of Health for
Versa HD II-85
Elekta Gains U.S. FDA 510(k) Approval for new Versa HD System II-85
The Christie NHS Foundation Trust Joins Consortium for
Developing MRI-guided Radiation Therapy System II-85
University Medical Center Installs First-ever MRI-guided
Radiation Therapy System II-85
The Netherlands Cancer Institute-Antoni van Leeuwenhoek
Hospital Joins Elekta and Royal Philips Consortium II-85
University of Texas MD Anderson Cancer Center Trust Joins
Elekta and Royal Philips Consortium II-86
Oncology Services International Takes Over Upstate Linac Services II-86
RTS Acquires OnCure Holdings II-86
Equra Health and Elekta Ink Long-term Agreement II-86
Radiation Oncology Resources and McKesson Specialty Health
Sign Multi-year Agreement II-86
Elekta Secures Order for Versa HD Systems from St. James's
Institute of Oncology II-86
RaySearch Laboratories and Hitachi Medical Sign Distribution
Agreement II-87
Spire Healthcare Enters into Partnership with Elekta II-87
RaySearch Laboratories Announces Research Collaboration with
Brainlab II-87
Oncology Services International Enters into Partnership with
D3 Oncology Solutions II-87
Oncology Systems and IBA Dosimetry Sign Distribution Agreement II-87
Ion Beam Applications Partners Apollo Hospitals to Establish
Proton Therapy Center II-87
Froedtert & The Medical College of Wisconsin Clinical Cancer
Center Joins Consortium for Developing MRI-guided Radiation
Therapy System II-88
Sunnybrook Health Sciences Centre Joins Consortium for
Developing MRI-guided Radiation Therapy System II-88
Varian Obtains FDA 510(k) Authorization for RapidPlan
Radiotherapy Treatment Planning Tool II-88
Varian Medical Systems Enters into Partnership with Siemens
Healthcare II-88
Accuray to Take Over Morphormics II-88
e2v Bags Contract from Accuray II-88
Northern Centre for Cancer Care to Purchase TrueBeam™ Devices
from Varian II-89
Elekta Signs MoU with MSM-MEDIMPEX II-89
Institut Curie Selects Radiotherapy Systems of Varian Medical
Systems II-89
Varian Medical Systems Establishes Subsidiary in South Korea II-89
NHS Supply Chain Enters into Agreement with Elekta II-89
Elekta Takes Over Radon II-89
Varian Bags Order to Equip Proton Therapy Facility II-89
Varian Medical Systems Secures SFDA Approval for UNIQUE™
Medical Linear Accelerator II-90
Mevion Medical Systems Receives FDA Approval for MEVION S250
Proton Therapy System II-90
Accuray Inks Agreement with German Cancer Research Center II-90
Nordion Announces Launch of Gamma Centre of Excellence II-90
14. FOCUS ON SELECT KEY PLAYERS II-91
Accuray Incorporated (US) II-91
BrainLab (Germany) II-91
Elekta AB (Sweden) II-91
Nucletron B.V. (The Netherlands) II-92
GE Healthcare (UK) II-92
Hitachi America (US) II-93
IBA Group (Belgium) II-93
Mitsubishi Electric Corporation (Japan) II-94
Nordion, Inc. II-94
Philips Healthcare (US) II-95
RaySearch (Sweden) II-95
Sumitomo Heavy Industries Ltd. (Japan) II-95
Varian Medical Systems, Inc. (US) II-96
15. GLOBAL MARKET PERSPECTIVE II-97
Table 29: World Recent Past, Current & Future Analysis for
Radiation Therapy Equipment by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), Middle East &
Africa and Latin American Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2013 through
2020 (includes corresponding Graph/Chart) II-97
Table 30: World Historic Review for Radiation Therapy
Equipment by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Middle East & Africa and Latin
American Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2006 through 2012 (includes
corresponding Graph/Chart) II-98
Table 31: World 15-Year Perspective for Radiation Therapy
Equipment by Geographic Region - Percentage Breakdown of Value
Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Middle East & Africa and Latin American Markets for
Years 2006, 2014 & 2020 (includes corresponding Graph/Chart) II-99
Table 32: World Recent Past, Current & Future Analysis for
Linear Accelerators by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Middle East & Africa
and Latin American Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2013 through 2020
(includes corresponding Graph/Chart) II-100
Table 33: World Historic Review for Linear Accelerators by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East & Africa and Latin American
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2006 through 2012 (includes
corresponding Graph/Chart) II-101
Table 34: World 15-Year Perspective for Linear Accelerators by
Geographic Region - Percentage Breakdown of Value Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Middle East & Africa and Latin American Markets for Years
2006, 2014 & 2020 (includes corresponding Graph/Chart) II-102
Table 35: World Recent Past, Current & Future Analysis for
Treatment Planning Systems by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), Middle East &
Africa and Latin American Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2013 through
2020 (includes corresponding Graph/Chart) II-103
Table 36: World Historic Review for Treatment Planning Systems
by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East & Africa and Latin American
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2006 through 2012 (includes
corresponding Graph/Chart) II-104
Table 37: World 15-Year Perspective for Treatment Planning
Systems by Geographic Region - Percentage Breakdown of Value
Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Middle East & Africa and Latin American Markets for
Years 2006, 2014 & 2020 (includes corresponding Graph/Chart) II-105
Table 38: World Recent Past, Current & Future Analysis for
Radiation Therapy Simulators by Geographic Region - US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle
East & Africa and Latin American Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2013 through 2020 (includes corresponding Graph/Chart) II-106
Table 39: World Historic Review for Radiation Therapy
Simulators by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Middle East & Africa and Latin
American Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2006 through 2012 (includes
corresponding Graph/Chart) II-107
Table 40: World 15-Year Perspective for Radiation Therapy
Simulators by Geographic Region - Percentage Breakdown of
Value Sales for US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East & Africa and Latin American
Markets for Years 2006, 2014 & 2020 (includes corresponding
Graph/Chart) II-108
III. MARKET
1. THE UNITED STATES III-1
A.Market Analysis III-1
Market Overview III-1
Radiation Therapy Market - An Insight III-1
Table 41: US Market for Hospital Cancer Therapies (2004 &
2015: Percentage Breakdown of Revenues by Treatment Type -
Surgery, Chemotherapy Drugs, Radiation Therapy,
Biotechnology-Based Drugs, and Others (includes
corresponding Graph/Chart) III-2
Replacements Drive Unit Installations III-3
Table 42: US Linacs Installed Base (2013): Percentage
Share Breakdown by Age of Equipment (includes
corresponding Graph/Chart) III-3
EHR Incentive Program Promotes Improvements in Efficiencies III-3
Recession Brings in More Worries for Cancer Patients III-4
Demographics Drive Radiation Therapy Market III-4
IMRT Market III-5
Innovations Propel Market Growth III-5
Demand on Rise for Treatment Planning Software III-6
Competition III-6
Table 43: Leading Players in the North American Radiation
Therapy Equipment Market (2013): Market Share Breakdown by
Volume Sales for Accuray, Elekta, and Varian (includes
corresponding Graph/Chart) III-7
Table 44: Leading Players in the North American Radiation
Therapy Equipment Market (2013): Market Share Breakdown by
Installed Base for Accuray, Elekta, Siemens and Varian
(includes corresponding Graph/Chart) III-7
Cancer Stats III-7
Table 45: New Cancer Cases in the US by Gender and Affected
Site: 2014E III-8
Table 46: New Cancer Cases in Males in US by Leading Site:
2014E (includes corresponding Graph/Chart) III-10
Table 47: New Cancer Cases in Females in US by Leading
Site: 2014E (includes corresponding Graph/Chart) III-11
Table 48: New Cancer Cases in US by State: 2014E III-12
Table 49: Incidence of Cancer for All Body Sites by Gender &
Age Group in the US (2013): New Cancer Cases for Males &
Females for the Age groups Under 45 years; 45 years and
Above; Under 65 years; and 65 years and Above (includes
corresponding Graph/Chart) III-14
Cancer Mortality Statistics III-15
Table 50: Cancer Related Deaths in the US by Gender and
Body Site: 2014E III-15
Table 51: Cancer Related Deaths in Males in US by Leading
Site: 2014E (includes corresponding Graph/Chart) III-17
Table 52: Cancer Related Deaths in Females in US by Leading
Site: 2014E (includes corresponding Graph/Chart) III-18
Table 53: Number of Deaths Related to Major Types of Cancer
in US by State: 2014E III-19
Table 54: Cancer Related Deaths in US by Age Group: 2012
(includes corresponding Graph/Chart) III-20
Reimbursement Scenario III-21
Coding III-21
Table 55: Reimbursement for Select Radiation Therapy Codes III-22
Product Introductions III-23
Strategic Corporate Developments III-23
Key Players III-26
B.Market Analytics III-28
Table 56: US Recent Past, Current & Future Analysis for
Radiation Therapy Equipment by Product Segment - Linear
Accelerator, Treatment Planning Systems, and Radiation
Therapy Simulators Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2013 through
2020 (includes corresponding Graph/Chart) III-28
Table 57: US Historic Review for Radiation Therapy Equipment
by Product Segment - Linear Accelerator, Treatment Planning
Systems, and Radiation Therapy Simulators Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-29
Table 58: US 15-Year Perspective for Radiation Therapy
Equipment by Product Segment - Percentage Breakdown of Value
Sales for Linear Accelerator, Treatment Planning Systems,
and Radiation Therapy Simulators Markets for Years 2006,
2014 & 2020 (includes corresponding Graph/Chart) III-30
Table 59: US Recent Past, Current & Future Analysis for
Proton Therapy Market with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-31
2. CANADA III-32
A.Market Analysis III-32
Current and Future Analysis III-32
Market Led by Replacement III-32
Cancer Statistics in Canada III-33
Table 60: New Cancer Cases in Canada by Gender and Affected
Site: 2014E (includes corresponding Graph/Chart) III-33
Table 61: New Cancer Cases in Canada by Province: 2014E
(includes corresponding Graph/Chart) III-34
Table 62: New Cancer Cases in Canada by Age Group: 2014E
(includes corresponding Graph/Chart) III-35
Table 63: Cancer Related Deaths in Canada by Gender and
Affected Site: 2014E (includes corresponding Graph/Chart) III-36
Table 64: Cancer Related Deaths in Canada by Province:
2014E (includes corresponding Graph/Chart) III-37
Table 65: Cancer Related Deaths in Canada by Age Group:
2014E (includes corresponding Graph/Chart) III-38
Product Introductions III-39
Strategic Corporate Development III-39
Key Player III-39
B.Market Analytics III-40
Table 66: Canadian Recent Past, Current & Future Analysis
for Radiation Therapy Equipment by Product Segment - Linear
Accelerator, Treatment Planning Systems, and Radiation
Therapy Simulators Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2013 through
2020 (includes corresponding Graph/Chart) III-40
Table 67: Canadian Historic Review for Radiation Therapy
Equipment by Product Segment - Linear Accelerator, Treatment
Planning Systems, and Radiation Therapy Simulators Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-41
Table 68: Canadian 15-Year Perspective for Radiation Therapy
Equipment by Product Segment - Percentage Breakdown of Value
Sales for Linear Accelerator, Treatment Planning Systems,
and Radiation Therapy Simulators Markets for Years 2006,
2014 & 2020 (includes corresponding Graph/Chart) III-42
3. JAPAN III-43
A.Market Analysis III-43
Current and Future Analysis III-43
Radiation Therapy Market - An Overview III-43
Table 69: Cancer Related Deaths by Age Groups: 2013
(includes corresponding Graph/Chart) III-44
Table 70: Japanese Radiation Therapy Equipment Market by
Leading Players (2013): Market Share Breakdown by New
Orders for Accuray, BrainLab, Elekta, and Varian (includes
corresponding Graph/Chart) III-45
Strategic Corporate Developments III-45
Select Players III-45
B.Market Analytics III-47
Table 71: Japanese Recent Past, Current & Future Analysis
for Radiation Therapy Equipment by Product Segment - Linear
Accelerator, Treatment Planning Systems, and Radiation
Therapy Simulators Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2013 through
2020 (includes corresponding Graph/Chart) III-47
Table 72: Japanese Historic Review for Radiation Therapy
Equipment by Product Segment - Linear Accelerator, Treatment
Planning Systems, and Radiation Therapy Simulators Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-48
Table 73: Japanese 15-Year Perspective for Radiation Therapy
Equipment by Product Segment - Percentage Breakdown of Value
Sales for Linear Accelerator, Treatment Planning Systems,
and Radiation Therapy Simulators Markets for Years 2006,
2014 & 2020 (includes corresponding Graph/Chart) III-49
Table 74: Japanese Recent Past, Current & Future Analysis
for Proton Therapy Market with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-50
4. EUROPE III-51
A.Market Analysis III-51
Current and Future Analysis III-51
Under-provision of Radiotherapy Units Offer New Opportunities III-51
Table 75: Europe Market for Radiation Therapy Equipment
(2013): Percentage Share Breakdown by Number of Treatment
Facilities for Germany, France, Italy, Spain and Others
(includes corresponding Graph/Chart) III-52
Table 76: Europe Market for Radiation Therapy Equipment
(2013): Percentage of Patients Receiving Radiation Therapy
across Select Countries (includes corresponding
Graph/Chart) III-52
Cancer Stats III-52
Table 77: Cancer Incidence in Europe by Site: 2012 (in
Thousands) (includes corresponding Graph/Chart) III-53
Table 78: Number of New Cancer Cases in Europe (2012-2030)
(In Million) (includes corresponding Graph/Chart) III-54
Key Players III-54
Table 79: Leading Players in European Radiation Therapy
Market (2013): Percentage Market Share Breakdown for
Elekta, Varian, and Others (includes corresponding
Graph/Chart) III-54
B.Market Analytics III-55
Table 80: European Recent Past, Current & Future Analysis
for Radiation Therapy Equipment by Geographic Region -
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-55
Table 81: European Historic Review for Radiation Therapy
Equipment by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2006 through 2012 (includes corresponding Graph/Chart) III-56
Table 82: European 15-Year Perspective for Radiation Therapy
Equipment by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets for Years 2006, 2014 & 2020
(includes corresponding Graph/Chart) III-57
Table 83: European Recent Past, Current & Future Analysis
for Radiation Therapy Equipment by Product Segment - Linear
Accelerator, Treatment Planning Systems, and Radiation
Therapy Simulators Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2013 through
2020 (includes corresponding Graph/Chart) III-58
Table 84: European Historic Review for Radiation Therapy
Equipment by Product Segment - Linear Accelerator, Treatment
Planning Systems, and Radiation Therapy Simulators Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-59
Table 85: European 15-Year Perspective for Radiation Therapy
Equipment by Product Segment - Percentage Breakdown of Value
Sales for Linear Accelerator, Treatment Planning Systems,
and Radiation Therapy Simulators Markets for Years 2006,
2014 & 2020 (includes corresponding Graph/Chart) III-60
Table 86: European Recent Past, Current & Future Analysis
for Proton Therapy Market with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-61
4a. FRANCE III-62
A.Market Analysis III-62
Current and Future Analysis III-62
Strategic Corporate Development III-62
B.Market Analytics III-63
Table 87: French Recent Past, Current & Future Analysis for
Radiation Therapy Equipment by Product Segment - Linear
Accelerator, Treatment Planning Systems, and Radiation
Therapy Simulators Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2013 through
2020 (includes corresponding Graph/Chart) III-63
Table 88: French Historic Review for Radiation Therapy
Equipment by Product Segment - Linear Accelerator, Treatment
Planning Systems, and Radiation Therapy Simulators Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-64
Table 89: French 15-Year Perspective for Radiation Therapy
Equipment by Product Segment - Percentage Breakdown of Value
Sales for Linear Accelerator, Treatment Planning Systems,
and Radiation Therapy Simulators Markets for Years 2006,
2014 & 2020 (includes corresponding Graph/Chart) III-65
4b. GERMANY III-66
A.Market Analysis III-66
Current and Future Analysis III-66
Strategic Corporate Development III-66
Brainlab - A Key German Player III-66
B.Market Analytics III-67
Table 90: German Recent Past, Current & Future Analysis for
Radiation Therapy Equipment by Product Segment - Linear
Accelerator, Treatment Planning Systems, and Radiation
Therapy Simulators Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2013 through
2020 (includes corresponding Graph/Chart) III-67
Table 91: German Historic Review for Radiation Therapy
Equipment by Product Segment - Linear Accelerator, Treatment
Planning Systems, and Radiation Therapy Simulators Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-68
Table 92: German 15-Year Perspective for Radiation Therapy
Equipment by Product Segment - Percentage Breakdown of Value
Sales for Linear Accelerator, Treatment Planning Systems,
and Radiation Therapy Simulators Markets for Years 2006,
2014 & 2020 (includes corresponding Graph/Chart) III-69
4c. ITALY III-70
A.Market Analysis III-70
Current and Future Analysis III-70
B.Market Analytics III-70
Table 93: Italian Recent Past, Current & Future Analysis for
Radiation Therapy Equipment by Product Segment - Linear
Accelerator, Treatment Planning Systems, and Radiation
Therapy Simulators Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2013 through
2020 (includes corresponding Graph/Chart) III-70
Table 94: Italian Historic Review for Radiation Therapy
Equipment by Product Segment - Linear Accelerator, Treatment
Planning Systems, and Radiation Therapy Simulators Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-71
Table 95: Italian 15-Year Perspective for Radiation Therapy
Equipment by Product Segment - Percentage Breakdown of Value
Sales for Linear Accelerator, Treatment Planning Systems,
and Radiation Therapy Simulators Markets for Years 2006,
2014 & 2020 (includes corresponding Graph/Chart) III-72
4d. THE UNITED KINGDOM III-73
A.Market Analysis III-73
Current and Future Analysis III-73
Product Introductions III-73
Strategic Corporate Developments III-73
B.Market Analytics III-75
Table 96: The UK Recent Past, Current & Future Analysis for
Radiation Therapy Equipment by Product Segment - Linear
Accelerator, Treatment Planning Systems, and Radiation
Therapy Simulators Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2013 through
2020 (includes corresponding Graph/Chart) III-75
Table 97: The UK Historic Review for Radiation Therapy
Equipment by Product Segment - Linear Accelerator, Treatment
Planning Systems, and Radiation Therapy Simulators Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-76
Table 98: The UK 15-Year Perspective for Radiation Therapy
Equipment by Product Segment - Percentage Breakdown of Value
Sales for Linear Accelerator, Treatment Planning Systems,
and Radiation Therapy Simulators Markets for Years 2006,
2014 & 2020 (includes corresponding Graph/Chart) III-77
4e. SPAIN III-78
A.Market Analysis III-78
Current and Future Analysis III-78
B.Market Analytics III-78
Table 99: Spanish Recent Past, Current & Future Analysis for
Radiation Therapy Equipment by Product Segment - Linear
Accelerator, Treatment Planning Systems, and Radiation
Therapy Simulators Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2013 through
2020 (includes corresponding Graph/Chart) III-78
Table 100: Spanish Historic Review for Radiation Therapy
Equipment by Product Segment - Linear Accelerator, Treatment
Planning Systems, and Radiation Therapy Simulators Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-79
Table 101: Spanish 15-Year Perspective for Radiation Therapy
Equipment by Product Segment - Percentage Breakdown of Value
Sales for Linear Accelerator, Treatment Planning Systems,
and Radiation Therapy Simulators Markets for Years 2006,
2014 & 2020 (includes corresponding Graph/Chart) III-80
4f. RUSSIA III-81
A.Market Analysis III-81
Current and Future Analysis III-81
Strategic Corporate Development III-81
B.Market Analytics III-82
Table 102: Russian Recent Past, Current & Future Analysis
for Radiation Therapy Equipment by Product Segment - Linear
Accelerator, Treatment Planning Systems, and Radiation
Therapy Simulators Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2013 through
2020 (includes corresponding Graph/Chart) III-82
Table 103: Russian Historic Review for Radiation Therapy
Equipment by Product Segment - Linear Accelerator, Treatment
Planning Systems, and Radiation Therapy Simulators Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-83
Table 104: Russian 15-Year Perspective for Radiation Therapy
Equipment by Product Segment - Percentage Breakdown of Value
Sales for Linear Accelerator, Treatment Planning Systems,
and Radiation Therapy Simulators Markets for Years 2006,
2014 & 2020 (includes corresponding Graph/Chart) III-84
4g. REST OF EUROPE III-85
A.Market Analysis III-85
Current and Future Analysis III-85
Product Introductions III-85
Strategic Corporate Developments III-85
Key Players III-86
B.Market Analytics III-89
Table 105: Rest of Europe Recent Past, Current & Future
Analysis for Radiation Therapy Equipment by Product Segment -
Linear Accelerator, Treatment Planning Systems, and
Radiation Therapy Simulators Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2013
through 2020 (includes corresponding Graph/Chart) III-89
Table 106: Rest of Europe Historic Review for Radiation
Therapy Equipment by Product Segment - Linear Accelerator,
Treatment Planning Systems, and Radiation Therapy Simulators
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-90
Table 107: Rest of Europe 15-Year Perspective for Radiation
Therapy Equipment by Product Segment - Percentage Breakdown
of Value Sales for Linear Accelerator, Treatment Planning
Systems, and Radiation Therapy Simulators Markets for Years
2006, 2014 & 2020 (includes corresponding Graph/Chart) III-91
5. ASIA-PACIFIC III-92
A.Market Analysis III-92
Current and Future Analysis III-92
Asia - A Potential Market for Radiation Therapy Equipment III-92
Table 108: Number of Beds in Public and Private Sector
Hospitals in China, India and Indonesia (2015) (includes
corresponding Graph/Chart) III-93
Table 109: Population Statistics in Asia (Including Japan) &
Percentage of Population Aged Above 65 Years (includes
corresponding Graph/Chart) III-94
Table 110: Installed Base of Clinical Accelerators in Asia
(includes corresponding Graph/Chart) III-95
Table 111: Market Potential for Clinical Accelerators in
Asia (Including Japan): Calculated in Terms of Thousands
of People Per Accelerator (includes corresponding
Graph/Chart) III-96
Cancer Statistics in Asia-Pacific III-96
Table 112: Cancer Incidence in Asia-Oceania by Site: 2011
(in Thousands) (includes corresponding Graph/Chart) III-97
Competitive Scenario III-97
Table 113: Asia-Pacific Market for Radiotherapy Equipment
and Software by Leading Players (2013): Market Share
Breakdown by New Orders for Accuray, Elekta, Varian, and
Others (includes corresponding Graph/Chart) III-98
B.Market Analytics III-99
Table 114: Asia-Pacific Recent Past, Current & Future
Analysis for Radiation Therapy Equipment by Geographic
Region - China, India and Rest of Asia-Pacific Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-99
Table 115: Asia-Pacific Historic Review for Radiation
Therapy Equipment by Geographic Region - China, India and
Rest of Asia-Pacific Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2006 through
2012 (includes corresponding Graph/Chart) III-100
Table 116: Asia-Pacific 15-Year Perspective for Radiation
Therapy Equipment by Geographic Region - Percentage
Breakdown of Value Sales for China, India and Rest of
Asia-Pacific Markets for Years 2006, 2014 & 2020 (includes
corresponding Graph/Chart) III-101
Table 117: Asia-Pacific Recent Past, Current & Future
Analysis for Radiation Therapy Equipment by Product Segment -
Linear Accelerator, Treatment Planning Systems, and
Radiation Therapy Simulators Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2013
through 2020 (includes corresponding Graph/Chart) III-102
Table 118: Asia-Pacific Historic Review for Radiation
Therapy Equipment by Product Segment - Linear Accelerator,
Treatment Planning Systems, and Radiation Therapy Simulators
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-103
Table 119: Asia-Pacific 15-Year Perspective for Radiation
Therapy Equipment by Product Segment - Percentage Breakdown
of Value Sales for Linear Accelerator, Treatment Planning
Systems, and Radiation Therapy Simulators Markets for Years
2006, 2014 & 2020 (includes corresponding Graph/Chart) III-104
Table 120: Asia-Pacific Recent Past, Current & Future
Analysis for Proton Therapy Market with Annual Sales Figures
in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-105
5a. CHINA III-106
A.Market Analysis III-106
Current and Future Analysis
Download the full report:
https://www.reportbuyer.com/product/98399/
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email:
Email Contact
Tel: +44 208 816 85 48
Website:
www.reportbuyer.com
To view the original version on PR Newswire, visit: http://www.prnewswire.com/news-releases/world-radiation-therapy-equipment-industry-300031803.html
SOURCE ReportBuyer
| Contact: |
| ReportBuyer
Web: http://www.reportbuyer.com |